Canada markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
85.52-1.71 (-1.96%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 553.3B
Enterprise Value 352.69B
Trailing P/E 67.60
Forward P/E 139.78
PEG Ratio (5 yr expected) 13.96
Price/Sales (ttm)12.20
Price/Book (mrq)12.65
Enterprise Value/Revenue 312.06
Enterprise Value/EBITDA 637.57

Trading Information

Stock Price History

Beta (5Y Monthly) 0.97
52-Week Change 312.07%
S&P500 52-Week Change 318.43%
52 Week High 392.08
52 Week Low 351.51
50-Day Moving Average 387.56
200-Day Moving Average 381.60

Share Statistics

Avg Vol (3 month) 32.48M
Avg Vol (10 day) 32.77M
Shares Outstanding 5623.25M
Float 618.17M
% Held by Insiders 10.68%
% Held by Institutions 187.59%
Shares Short (Dec. 30, 2020) 44.64M
Short Ratio (Dec. 30, 2020) 42.09
Short % of Float (Dec. 30, 2020) 40.76%
Short % of Shares Outstanding (Dec. 30, 2020) 40.74%
Shares Short (prior month Nov. 29, 2020) 45.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3May 31, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 18.18%
Operating Margin (ttm)29.85%

Management Effectiveness

Return on Assets (ttm)12.77%
Return on Equity (ttm)19.79%

Income Statement

Revenue (ttm)4.37B
Revenue Per Share (ttm)7.01
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)3.23B
EBITDA 1.4B
Net Income Avi to Common (ttm)794.1M
Diluted EPS (ttm)1.26
Quarterly Earnings Growth (yoy)18.40%

Balance Sheet

Total Cash (mrq)1.3B
Total Cash Per Share (mrq)2.08
Total Debt (mrq)690.1M
Total Debt/Equity (mrq)16.39
Current Ratio (mrq)3.52
Book Value Per Share (mrq)6.76

Cash Flow Statement

Operating Cash Flow (ttm)1.05B
Levered Free Cash Flow (ttm)393.46M